FDA Adverse Event Malfunction Summary report: N

COULTER ACT 10

MDR report key: 1011826 · Received March 11, 2008

Report

Report Number
1061932-2008-00012
Event Type
Malfunction
Date Received
March 11, 2008
Date of Event
February 14, 2008
Report Date
March 11, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
GKZ
PMA / PMN Number
K964988
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE SPECIMEN WAS COLLECTED, VIA VENIPUNCTURE, IN A 3ML BD TUBE, AND WAS STORED AT ROOM TEMPERATURE. THE ERRONEOUS RESULTS OCCURRED IN A WHOLE BLOOD MODE OF OPERATION FOR A SPECIFIC SAMPLE. THE INSTRUMENT IS WORKING WITHIN QC SPECS. A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO THE CUSTOMER'S LAB: THE FSE REPLACED RBC COUNT VALVE, SWEEP FLOW, AND TRIPLE SYRINGE. THE FSE VERIFIED THE INSTRUMENT. AS OF 02/25/08, THERE HAVE BEEN NO FURTHER ISSUES OF LOW RESULT RECOVERY FROM THIS ACCOUNT. HARDWARE ISSUE MAY HAVE CONTRIBUTED TO THIS EVENT; HOWEVER, A CLEAR ROOT CAUSE HAS NOT BEEN DETERMINED TO DATE. A MALFUNCTION WILL BE ASSUMED FOR THE PURPOSE OF THIS REPORT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) AND REPORTED THAT PLATELET (PLT) RESULTS GENERATED BY THE COULTER ACT 10 ANALYZER DID NOT CORRELATE WITH A REFERENCE LAB RESULT FOR THE SAME SAMPLE. THE INITIAL PLT RESULT WAS 108X10 TO THE THIRD POWER CELLS/UL. THE SAMPLE WAS RETESTED AND REPEATED RESULT WAS 126X10 TO THE THIRD POWER CELLS/UL. THE SAMPLE WAS TESTED AT A REFERENCE LAB AND PLT RESULT OF 225X10 TO THE THIRD POWER CELLS/UL WAS OBTAINED. ERRONEOUS RESULTS WERE NOT REPORTED OUT OF THE LAB. BASED ON AVAILABLE INFORMATION, THERE WAS NO DEATH, INJURY, OR CHANGE TO PATIENT TREATMENT AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COULTER ACT 10 AUTOMATED DIFFERENTIAL CELL COUNTER GKZ BECKMAN COULTER, INC. ACT 10 NA

Patients

Seq Age Sex Outcome Treatment
1 NA